Literature DB >> 9217198

Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes.

K M Champion1, J G Gilbert, F A Asimakopoulos, S Hinshelwood, A R Green.   

Abstract

Studies of X chromosome inactivation patterns are central to many aspects of our understanding of the pathogenesis of haematological malignancies. In patients with myeloproliferative disorders and myelodysplastic syndromes the demonstration of skewed X inactivation patterns in multiple haemopoietic lineages has been taken to indicate a stem cell origin for these groups of diseases. However, stem cell depletion or selection pressures can also produce skewed X inactivation patterns and might increase with age. We have therefore used the HUMARA assay to study X inactivation patterns of elderly patients with myeloproliferative disorders together with an age-matched control group of normal elderly women. A clonal pattern (clonal granulocytes and polyclonal T cells) was observed in 23.1% of normal women and 63.4% of patients with myeloproliferative disorders. This is the first report of X inactivation patterns in purified subpopulations of blood cells in normal elderly women. These results have three significant implications. Firstly, the finding of clonal granulocytes and polyclonal T cells in normal elderly women is likely to reflect age-related stem cell depletion or selection pressures. Secondly, the demonstration of clonal granulocytes and polyclonal T cells is not a useful diagnostic marker for myeloproliferative disorders or myelodysplastic syndromes in elderly women. Thirdly, our data raise the possibility that clonal blood cell patterns may precede rather than follow mutations which subsequently give rise to myelodysplastic or myeloproliferative phenotypes.

Entities:  

Mesh:

Year:  1997        PMID: 9217198     DOI: 10.1046/j.1365-2141.1997.1933010.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  35 in total

Review 1.  Clonal hematopoiesis.

Authors:  Max Jan; Benjamin L Ebert; Siddhartha Jaiswal
Journal:  Semin Hematol       Date:  2016-10-20       Impact factor: 3.851

2.  Methylation of AR locus does not always reflect X chromosome inactivation state.

Authors:  Sabina I Swierczek; Lucie Piterkova; Jaroslav Jelinek; Neeraj Agarwal; Sue Hammoud; Andrew Wilson; Kimberly Hickman; Charles J Parker; Bradley R Cairns; Bradley Cairns; Josef T Prchal
Journal:  Blood       Date:  2012-01-27       Impact factor: 22.113

3.  Hematopoiesis is not clonal in healthy elderly women.

Authors:  Sabina I Swierczek; Neeraj Agarwal; Roberto H Nussenzveig; Gerald Rothstein; Andrew Wilson; Andrew Artz; Josef T Prchal
Journal:  Blood       Date:  2008-07-18       Impact factor: 22.113

4.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors:  David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

5.  Analysis of expansion of myeloid progenitors in mice to identify leukemic susceptibility genes.

Authors:  Vincent E Sollars; Ed Pequignot; Jay L Rothstein; Arthur M Buchberg
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

6.  X-chromosome genetic association test accounting for X-inactivation, skewed X-inactivation, and escape from X-inactivation.

Authors:  Jian Wang; Robert Yu; Sanjay Shete
Journal:  Genet Epidemiol       Date:  2014-07-08       Impact factor: 2.135

7.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.

Authors:  Florian Zink; Simon N Stacey; Gudmundur L Norddahl; Michael L Frigge; Olafur T Magnusson; Ingileif Jonsdottir; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Sigurjon A Gudjonsson; Julius Gudmundsson; Jon G Jonasson; Laufey Tryggvadottir; Thorvaldur Jonsson; Agnar Helgason; Arnaldur Gylfason; Patrick Sulem; Thorunn Rafnar; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Gisli Masson; Augustine Kong; Kari Stefansson
Journal:  Blood       Date:  2017-05-08       Impact factor: 22.113

8.  Quantification of clonal hematopoiesis in polycythemia vera.

Authors:  Udo Siebolts; Murat Ates; Rüdiger Spitz; Jürgen Thiele; Claudia Wickenhauser
Journal:  Virchows Arch       Date:  2005-08-19       Impact factor: 4.064

9.  Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study.

Authors:  Roberto Latagliata; Dario Ferrero; Alessandra Iurlo; Francesco Cavazzini; Fausto Castagnetti; Elisabetta Abruzzese; Carmen Fava; Massimo Breccia; Mario Annunziata; Fabio Stagno; Mario Tiribelli; Gianni Binotto; Giovanna Mansueto; Antonella Gozzini; Sabina Russo; Laura Cavalli; Enrico Montefusco; Gabriele Gugliotta; Michele Cedrone; Antonella Russo Rossi; Paolo Avanzini; Patrizia Pregno; Endri Mauro; Antonio Spadea; Francesca Celesti; Gianfranco Giglio; Alessandro Isidori; Monica Crugnola; Elisabetta Calistri; Federica Sorà; Stefano Storti; Ada D'Addosio; Giovanna Rege-Cambrin; Luigiana Luciano; Giuliana Alimena
Journal:  Drugs Aging       Date:  2013-08       Impact factor: 3.923

Review 10.  Sixty as the new forty: considerations on older related stem cell donors.

Authors:  P Anderlini
Journal:  Bone Marrow Transplant       Date:  2016-08-08       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.